5th Annual Microbiome Movement – Drug Development Summit
Topic: A Novel Machine Learning Approach to Microbiome Based Biomarker Discovery
Time: October 19, 2020 at 12:00pm EDT
- The need and challenges in microbiome-based biomarker discovery
- Using a novel cloud based computational approach utilizing machine learning to identify biomarkers
- Sharing examples of biomarker discovery
Panel Discussion: Reviewing the Role of the Human Microbiome in Biomarker Discovery & Development
Time: October 19, 2020 at 12:30pm EDT
- When we think about PK, what does that mean for the different microbiome-based drug modalities (LBPs, small molecules, GMO, Natural products etc.)
- Highlighting the importance of dosing and dosing strategies and how that relates to PK/PD
- Discussing how regulatory agencies look at IBD biomarkers when assessing the relative efficacy of microbiome-based therapeutics
Topic: Customized Phage Therapies for Chronic Disease
Time: October 20, 2020 at 2:00pm EDT
- Phage therapy as a promising modality to eradicate harmful bacteria
- BX001 a topically administered phage cocktail for acne
- Phage therapy for treating IBD and PSC